Utilities, Consumer...
Services: Diversified Services
Qiagen NV (QGEN: NASDAQ)
$15.69 -0.15 | -0.95%
02/08/12 - 04:00 PM ET
984.32K / 1.63M
Vol / Avg. Vol:15.85 / 15.84
Open / Prev. Close:15.64 - 15.94
Today's Range:12.47 - 22.20
52 Wk Range:13.61%
Performance YTD:TheStreet Rating:
Portfolios with QGEN
- Portfolio NameUser Type
- UserVegasDC
- ContributorBarron's Summary 3-06-2010
- UserPART 5 JPMorgan 28th Annual...
- ContributorBarron's Summary 11-07-2009
- UserTop Biotech Short Squeeze P...
- UserPART 5 JPMorgan 27th Annual...
- UserTop Biotech Short Squeeze P...
- UserBarron's Research Reports 7...
- UserCFR
- Usermicahw29 Portfolio 1
Latest QGEN Headlines from TheStreet
- QIAGEN's CEO Discusses Q4 2011 Results - Earnings Call Transcript 02.01.12 | 06:02 pm
- Qiagen NV (QGEN): Today's Featured Diversified Services Loser 12.02.11 | 05:12 pm
- QIAGEN's CEO Hosts Investor Day - Conference Call Transcript 11.18.11 | 06:11 am
- QIAGEN's CEO Discusses Q3 2011 Results - Earnings Call Transcript 11.03.11 | 03:11 pm
- 7 Stocks Rising on Huge Volume 11.03.11 | 12:11 pm
- Qiagen Stock Hits New 52-Week Low (QGEN) 10.18.11 | 10:10 am
- Qiagen Stock Hits New 52-Week Low (QGEN) 10.05.11 | 09:10 am
- Qiagen Stock Hits New 52-Week Low (QGEN) 09.22.11 | 10:09 am
- Qiagen Stock Hits New 52-Week Low (QGEN) 09.09.11 | 11:09 am
- Qiagen Stock Hits New 52-Week Low (QGEN) 08.10.11 | 10:08 am
Press Releases for QGEN
- QIAGEN Reports Fourth Quarter And Full-Year 2011 Results - PR Newswire 01.31.12 | 04:01 pm
- QIAGEN Gains Rights To Genomic Biomarkers For Lung, Brain And Other Cancers To Expand Its Pipeline Of Companion Diagnostics - PR Newswire 01.10.12 | 01:01 am
- QIAGEN And Max Planck Institute For Infection Biology Collaborate To Develop Assay For Active TB Risk In Individuals With Latent Infection - PR Newswire 01.09.12 | 02:01 am
- QIAGEN Launches QIAensemble Decapper Sample Preparation Automation System - PR Newswire 01.06.12 | 02:01 am
- QIAGEN Launches Project To Improve Efficiency And Resource Allocation - PR Newswire 11.28.11 | 04:11 pm
- QIAGEN Reports Third Quarter 2011 Results - PR Newswire 11.02.11 | 04:11 pm
- Webcast Of QIAGEN N.V. (NASDAQ: QGEN) Third Quarter 2011 Financial Results Call Set For November 3 - PR Newswire 10.07.11 | 01:10 pm
- QIAGEN To Develop New Companion Diagnostic For Compound In Clinical Trials For Blood Cancers - PR Newswire 09.06.11 | 01:09 am
- QIAGEN Completes Acquisition Of Cellestis Limited - PR Newswire 08.29.11 | 01:08 am
- QIAGEN And Pfizer Partner To Develop Companion Diagnostic For Novel Compound In Global Clinical Trials For Lung Cancer - PR Newswire 08.16.11 | 02:08 am
Partner Headlines for QGEN
- Response Genetics Stock Soars 31% On $7.8M Offering News - Seeking Alpha 02.03.12 | 08:02 am
- Qiagen Posts a Solid 4Q - Analyst Blog - Zacks 02.01.12 | 10:02 am
- Myriad Beats, Raises Guidance - Analyst Blog - Zacks 02.01.12 | 09:02 am
- Qiagen Expands QIAensemble Portfolio - Analyst Blog - Zacks 01.09.12 | 07:01 pm
- Top 5 Nasdaq 100 Stocks To Consider Now - Seeking Alpha 11.21.11 | 08:11 am
- Hologic Beats Estimates - Analyst Blog - Zacks 11.08.11 | 09:11 am
- European Watchdog OKs Pfizer Drugs - Analyst Blog - Zacks 08.18.11 | 06:08 pm
- Myriad on Share Buyback Spree - Analyst Blog - Zacks 08.17.11 | 05:08 pm
- Qiagen EPS In Line, Guidance Low - Analyst Blog - Zacks 07.27.11 | 05:07 pm
- Life Ties Up with Pharma Majors - Analyst Blog - Zacks 06.27.11 | 10:06 am
